Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Our understanding of social anxiety disorder (also known as social phobia) has moved from
rudimentary awareness that it is not merely shyness to a much more sophisticated …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Abstract The Sheehan Disability Scale (SDS) is a patient-rated, discretized analog measure
of functional disability in work, social, and family life. Its increasing use in clinical trials in …

Welcome to the fifth edition of a very handy and useful book, the Manual of Clinical
Psychopharmacology. Readers familiar with any of the previous editions are already aware …

Background We aimed to examine the efficacy of selective serotonin reuptake inhibitors
(SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) for anxiety disorders …

Background The cause of the obesity epidemic is multifactorial, but may, in part, be related
to medication-induced weight gain. While clinicians may strive to do their best to select …

Social anxiety disorder (SAD), also referred to as social phobia, is characterized by
persistent fear and avoidance of social situations due to fears of evaluation by others. SAD …

Background: Biases in adverse effect reporting in randomized controlled trials (RCTs)[eg
due to investigator expectations or assessment quality] can be quantified by studying the …

Background Recognition is growing that social anxiety disorder (SAnD) is a chronic and
disabling disorder, and data from early trials demonstrate that medication may be effective in …